• Compliance & Enforcement

  COMPLIANCE & ENFORCEMENT Unlicensed software is unauthorized use or distribution of copyrighted software. It includes downloading, sharing, selling, or installing multiple copies of licensed software. Unlicensed software use also includes license infringement – installing a piece of software more times than the license permits – as well as sharing software license codes, uploading software codes to websites so others can download and use it, sharing software license codes or activation kFew readers

• NLS Copyright Certificates

  Proof of Copyrights Transfer and USA Registration Although our NLS Software Copyright was registered in 2010 in Russia, Copyright is acquired automatically when an original work is generated, the creator is not required to register or mark the work with the copyright symbol in order to be protected. The rights holder is granted: the exclusive right of reproduction, the right to rent the software, the right to restrain others from renting the software and the right to assign or license the copFew readers

• APX/AMS Services - Self Attestation

  Our mission is to create a more enlightened way of working by providing an intuitive, unified platform to keep your content safe and accessible while helping you and those you work with stay coordinated and in sync. Our terms of service (“Terms”) cover your use and access to our services, client software and websites ("Services"). Please follow tFew readers

• End User Licesne Agreement (EULA)

  This licence agreement is supplementary to our general terms of business and applies for all contracts relating to software products. If you do not agree with the terms of the licence agreement, you must not install the software product. BY USING THE SOFTWARE, YOU AGREE TO THE TERMS OF THIS AGREEMENT. IF YOU DO NOT ACCEPT THESE TERMS, YOU ARE NOT ENTITLED TO USE THE SOFTWARE. This software copyright is owned by our Biostar Technology International, LLC. This agreeFew readers

• FDA Fraudulent (COVID-19) Policy

  The U.S. Food and Drug Administration is issuing warning letters to firms for selling fraudulent products with claims to prevent, treat, mitigate, diagnose or cure coronavirus disease 2019 (COVID-19). We are actively monitoring for any firms marketing products with fraudulent COVID-19 prevention and treatment claims. The FDA is exercising its authority to protect consumers from firms selling unapproved products and making false or misleading claims, including, by pursuing warniFew readers

• Acceptable Use Policy

  (“Biostar”) is used by healthcare professionals or health enthusiasts and we're proud of the trust placed in us. In exchange, we trust you to use our services responsibly. You agree not to misuse the (“Biostar”) hardware, software, and intellectual properties (e.g. trademark, copyrights) and/or misuse the ("Services") or help anyone else to do so. For example, you must not even try to do any of the following in connection with the Services: • probe, scan, or test thFew readers

• Terms of Service

  Posted: July 6, 2021 Effective: July 6, 2021 Thanks for using (“Biostar”) Services. Our mission is to create a more enlightened way of working by providing an intuitive, unified platform to keep your content safe and accessible while helping you and those you work with stay coordinated and in sync. These terms of service (“TFew readers

• 2022 Agreement Updates

  So we’re letting you know about a few updates to our (“Biostar”) Business Agreement, Terms of Service, and Privacy Policy, focusing on: • Clarification that (“Biostar”) may only be used by those over 18 in the United States, and 18 outside of the United States; • Updates to our dispute resolution terms; • SupportingFew readers

• DMCA Policy

  (“Biostar”) respects the intellectual property rights of others and expects its users to do the same. In accordance with the Digital Millennium Copyright Act of 1998, the text of which may be found on the U.S. Copyright Office website at http://www.copyright.gov/legislation/dmca.pdf, (“Biostar”) will respond expeditiously to claims of copyright infringement committed using the (“Biostar”) service and/or the (“Biostar”) website (the “Site”) if such claims are reported to (“Biostar”)Few readers